Basic Information
Biorthex is a biotechnology company that designs, develops, manufactures, and markets innovative and proprietary surgical products for the treatment of spinal diseases. The company is committed to providing the surgical community with safe, technically proven, and innovative spinal implants for treating spinal disorders, diseases, and injuries. Biorthex's primary focus is on the commercialization of its innovative spinal interbody fusion implants, starting with its Actipore technology platform and its expansion. Actipore is a porous biomaterial derived from nitinol technology that allows bone cells to grow into the pores of the biomaterial, enabling rapid and secure attachment to the bone structure without the need for bone grafts or fibrous tissue.